Home > Name List By other > (2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N', 3-dihydroxy-2-(2-methylpropyl)butanediamide

CAS No 154039-60-8 , (2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',
3-dihydroxy-2-(2-methylpropyl)butanediamide

  • Name: (2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',
    3-dihydroxy-2-(2-methylpropyl)butanediamide
  • Synonyms: CHEBI:50662;Marimastat [USAN]; D03795; 154039-60-8; BB 2516; CHEMBL279785; AC1L3O2N; BB-2516;(2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',
    3-dihydroxy-2-(2-methylpropyl)butanediamide; Marimastat (USAN/INN);
  • CAS Registry Number:
  • Flash Point: °C
  • Boiling Point: °Cat760mmHg
  • Density: 1.14g/cm3
  • Refractive index: 1.498
  • Flash Point: °C
  • Molecular Weight: 331.40786
  • InchiKey: OCSMOTCMPXTDND-OUAUKWLOSA-N
  • InChI: InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)
    15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,
    11-/m1/s1
  • Molecular Formula: C15H29N3O5
  • Molecular Structure:CAS No:154039-60-8 (2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',<br />3-dihydroxy-2-(2-methylpropyl)butanediamide

Related products

Search by region :

Select to

154039-60-8 Marimastat

  • Marimastat Marimastat(BB 2516; TA2516) is a broad spectrum inhibitor of MMPs (IC50 values are 3, 5, 6, 9 and 13 nM for MMP-9, MMP-1, MMP-2, MMP-14 and MMP-7 respectively). Target: Proteasome Product Links: http://www.medchemexpress.cn/marimastat.html...
  • United States MedChemexpress LLC [Manufacturer]
  • Tel: 609-228-6898
  • Fax: --
  • Address: 18 Wilkinson Way, Princeton, NJ 08540, USA Princeton,New JerseyUnited States
Contact Supplier

154039-60-8 Marimastat

  • United States LGM Pharma [Manufacturer]
  • Tel: 561-981-9994
  • Fax: 561-892-0580
  • Address: 922 Clint Moore Road
    Boca Raton, FL 33487 null,nullUnited States
Contact Supplier

154039-60-8 Marimastat

  • Marimastat, Min 99%
  • China Finechemie Co., Ltd. [Manufacturer]
  • Tel: +86-23-99186710
  • Fax: +86-23-99186729
  • Address: 28th Floor Mordern Building,New-Tech Zone400020 ChongqingCHINA Chongqing,nullChina
Contact Supplier

154039-60-8 (2S,3R)-N4-[(1S)-2,2-Dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)butanediamide

  • (2S,3R)-N4-[(1S)-2,2-Dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)butanediamideMarimastat, >98%
  • United Kingdom Tocris Bioscience [Manufacturer]
  • Tel: + 44 (0)117 916 3333
  • Fax: + 44 (0)117 916 3344
  • Address: Tocris Bioscience Tocris House Hung Road BS11 9XJ BristolUNITED KINGDOM BS11 9XJ Bristol,nullUnited Kingdom
Contact Supplier

154039-60-8 3R-(2,2-DIMETHYL-1S-METHYLCARBAMOYL-PROPYLCARBAMOYL)-2S-HYDROXY-5-METHYL-HEXANOHYDROXAMIC ACID

  • China Nanjing Chemlin Chemical Industry Co.,Ltd. [Manufacturer]
  • Tel: +86 25 8369-7070/ +86 138 51816776 (Mobile)
  • Fax: +86 25 8345-3275
  • Address: Rm.902 Longyin Plaza,
    No. 217 Zhongshan Rd.
    (N)Nanjing 210009,China null,nullChina
Contact Supplier

Select to

1/1
References of (2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',
3-dihydroxy-2-(2-methylpropyl)butanediamide
Title: Marimastat
CAS Registry Number: 154039-60-8
CAS Name: (2S,3R)-N4-[(1S)-2,2-Dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)butanediamide
Synonyms: N2-[3S-hydroxy-4-(N-hydroxyamino)-2R-isobutylsuccinyl]-L-tert-leucine-N1-methylamide
Manufacturers' Codes: BB-2516
Molecular Formula: C15H29N3O5
Molecular Weight: 331.41
Percent Composition: C 54.36%, H 8.82%, N 12.68%, O 24.14%
Literature References: Synthetic matrix metalloproteinase inhibitor (MMPI). Prepn: J. P. Dickens et al., WO 9402447; eidem, US 5700838 (1994, 1997 both to British Biotech) and structure-activity study: D. E. Levy et al., J. Med. Chem. 41, 199 (1998). Improved synthesis: R. J. Davenport, R. J. Watson, Tetrahedron Lett. 41, 7983 (2000). Clinical study in pancreatic cancer: S. R. Bramhall et al., J. Clin. Oncol. 19, 3447 (2001); in gastric cancer: idem et al., Br. J. Cancer 86, 1864 (2002). Review of pharmacology: H. S. Rasmussen, P. P. McCann, Pharmacol. Ther. 75, 69-75 (1997); and clinical development: A. L. Thomas, W. P. Steward, Expert Opin. Invest. Drugs 9, 2913-2922 (2000). Review of structure-activity and mechanism of action: M. Whittaker et al., Chem. Rev. 99, 2735-2776 (1999).
Properties: Soly in water: 1.4 mg/ml.
Therap-Cat: Antineoplastic.
Keywords: Antineoplastic Adjunct; Antimetastatic Agent.